Fierce Pharma

OCTOBER 21, 2024

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too. | As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too.

Patients 300

Patients 300

MedCity News

OCTOBER 21, 2024

Recent failures in the retail health space beg the question: Is primary care only suited to remain within traditional players? Four healthcare executives shared their responses to this question during a panel at HLTH in Las Vegas. The post Can Primary Care Thrive Outside of Traditional Healthcare Players? appeared first on MedCity News.

Healthcare 118

Healthcare Healthcare Retail 118

Fierce Pharma

OCTOBER 21, 2024

Sanofi is now in “exclusive negotiations” with U.S. | Sanofi is now in “exclusive negotiations" with U.S. private equity firm Clayton, Dubilier & Rice to sell a 50% controlling stake in its consumer health business Opella, the company said. The deal values the consumer group at 16 billion euros.

249

249

MedCity News

OCTOBER 21, 2024

During HLTH 2024, Blue Shield of California and Salesforce announced a partnership that will streamline the prior authorization process. The post Blue Shield of California, Salesforce Partner to Modernize Prior Authorization appeared first on MedCity News.

116

116

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

OCTOBER 21, 2024

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights. | Starboard, which recently pitched turnaround plans to Pfizer, reportedly thinks the J&J consumer health spinout's stocks have underperformed since its market debut over a year ago.

Marketing 234

Marketing 234

MedCity News

OCTOBER 21, 2024

The FDA approved Astellas’s Vyloy as a treatment for advanced cases of gastric or gastroesophageal junction (GEJ) adenocarcinoma positive for a protein called claudin 18.2. It’s the first FDA-approved therapy for this target. The post Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer appeared first on MedCity News.

Pharma 113

Pharma FDA Biopharma 113

MedCity News

OCTOBER 21, 2024

Within a matter of months, we’re likely to see substantial growth in the number of EP ablation procedures performed in surgery centers outside the hospital. Here’s what we can expect. The post How the Move of Ablation Procedures into Surgery Centers Will Transform Electrophysiology appeared first on MedCity News.

114

114

Fierce Pharma

OCTOBER 21, 2024

Following a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. | As part of a new round of layoffs, certain Takeda staffers at two Massachusetts sites are set to lose their jobs. This marks the third round of job cuts Takeda has initiated in the state since it revealed a large restructuring drive in May.

269

269

pharmaphorum

OCTOBER 21, 2024

An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024

118

118

MedCity News

OCTOBER 21, 2024

Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches. The post The Funding Model for Cancer Innovation is Broken — We Can Fix It appeared first on MedCity News.

Medical 101

Medical 101

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Spotio

OCTOBER 21, 2024

Designing sales territories has never been more important for door to door and field sales teams. Unfortunately, designing sales territories is a process that the majority of sales managers rush through. Aligning territory design with business priorities is crucial, as poor planning is a major issue impacting sales reps’ ability to meet quotas.

Sales territory 98

Sales territory Sales Prospecting Leads 98

pharmaphorum

OCTOBER 21, 2024

Seaport Therapeutics completes a $225m Series B to fund its improved therapies for depression and anxiety, just months after raising $100m on its debut

102

102

PharmaVoice

OCTOBER 21, 2024

Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.

Patients 98

Patients 98

pharmaphorum

OCTOBER 21, 2024

A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for the drug.Vabysmo (faricimab) has been approved by the FDA for treating DME since 2022, quickly becoming one of the Swiss pharma group's fastest-growing products with sales of $1.1 billion in the first half of the year.

FDA 92

FDA Sales Pharma Patients 92

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

OCTOBER 21, 2024

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis pigmentosa (RP).

Patients 98

Patients 98

pharmaphorum

OCTOBER 21, 2024

Two digital therapeutics for addiction are available again through PursueCare, which acquired them from now-defunct Pear Tx last year

107

107

PharmaTech

OCTOBER 21, 2024

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

Patients 105

Patients 105

pharmaphorum

OCTOBER 21, 2024

Novo Nordisk's TFPI drug concizumab has been backed for approval in the EU to prevent bleeding episodes in people with haemophilia and inhibitors

92

92

Advertisement

PharmaVoice

OCTOBER 21, 2024

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

FDA 69

FDA 69

Pharmaceutical Commerce

OCTOBER 21, 2024

In this video interview with Pharma Commerce Editor Nicholas Saraceno, Jeffrey Bernstein, director of cybersecurity and data privacy for Kaufman Rossin’s risk advisory services, explains the top mistakes healthcare organizations make when building and maintaining their software.

Pharma 64

Pharma Healthcare Healthcare 64

PharmaTimes

OCTOBER 21, 2024

Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK

90

90

Pharmaceutical Technology

OCTOBER 21, 2024

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.

FDA 69

FDA Pharma 69

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

OCTOBER 21, 2024

The five new programmes are designed to fit alongside full-time work and clinical practice

Healthcare 88

Healthcare Healthcare Education Medical 88

PharmaTech

OCTOBER 21, 2024

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics.

Pharma 52

Pharma 52

European Pharmaceutical Review

OCTOBER 21, 2024

For the first time, a study has described the success application of a combination of allicin and domiphen to “control biofilm formation by pathogenic microorganisms”. Specifically, the two small molecule drugs were studied against the pathogens Staphylococcus aureus , Escherichia coli , and Candida albicans. The combination reduced the dosage of the two drugs and “demonstrated improved antimicrobial and anti-biofilm properties”.

Pharmaceutical 52

Pharmaceutical 52

PharmaTech

OCTOBER 21, 2024

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, spoke on recent challenges and trends in softgel formulations.

Pharma 52

Pharma 52

Advertisement

Distribution

PharmExec

OCTOBER 21, 2024

In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.

Patients 52

Patients Education Pharmaceutical 52

pharmaphorum

OCTOBER 21, 2024

In a new webinar with Atlas Clinical Research’s Chief Executive Officer Mark Scullion and Terttu Haring, President of Sites & Patients at Syneos Health and former investigator, learn more about the site experience for clinical research sites – including the important need for a partner who understands the challenges and drives solutions that can ease burden, create a better experience, and expand access and representation in clinical research for patients.

Patients 52

Patients 52

PharmaTech

OCTOBER 21, 2024

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights of his talk at AAPS PharmSci 360.

52

52

PharmExec

OCTOBER 21, 2024

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how personalized audio will be utilized within the pharma marketing industry in 2025.

Marketing 52

Marketing Pharma Pharmaceutical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales